Ventyx Biosciences, Inc. (NASDAQ:VTYX – Get Free Report) insider John Nuss sold 12,675 shares of the stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $7.72, for a total transaction of $97,851.00. Following the completion of the transaction, the insider owned 489,481 shares of the company’s stock, […]

Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) insider Derek Maetzold sold 509 shares of the firm’s stock in a transaction dated Wednesday, December 17th. The stock was sold at an average price of $40.04, for a total transaction of $20,380.36. Following the completion of the sale, the insider directly owned 34,360 shares of the […]